For more than two decades, scientists Scripps Research CenterIn the United States, they aim for ambivalent purpose: to create one HIV vaccine. And even if it is not the goal, there are advances that they hope to achieve.
It's the newest development experimental vaccine human beings have responded very much by chimpanzees. This vaccine leaves special antibodies that neutralize the tension of HIV that infects humans. Tier 2 Virus.
"This antibacterial neutralizer, as it enters the vaccine body, protects against antivirus animals as it happens in the real world," said the doctor. Dennis Burton, Head of the Center for Immunology and Microbiology.
The discovery of these antibodies is based on the work carried out by the Scripps Research Center since 1990: they help identify rare viral vulnerable to HIV and create a system of immunity. specific antibodies attacks on these places.
"As a result of HIV, it is the first scientific proof that the protection against HIV-based Tier 2 strain has been developed," said one of the authors of the study. "It's the question that continuesHow can we get the same result with chimpanzees and other animals?
Today, the vaccine will continue in an experimentation phase for animals and their creators will wait for their permission to start soon tests with humans.
More news on MSN:
This is how vaccines work. Expansion video.